Identification of Potential Therapeutic Targets in the Liver of Pioglitazone-Treated Type 2 Diabetes Sprague-Dawley Rats via Expression Profile Chip and iTRAQ Assay

Table 3

Transcriptomic and proteomic conjoint analysis of potential targets.

Gene symbol	Transcriptomics		Proteomics		Regulation
	Log (Pio versus DM)	Log (Con versus DM)	Pio versus DM	Con versus DM
Cyp7a1	−0.06	−1.52	0.488	0.361	Down
Cp	−0.17	−1.15	0.826	0.648	Down
RT1-EC2	0.21	0.24	1.255	1.204	Up